BANK OF AMERICA CORP /DE/ - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 87 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$115,663
-14.9%
36,602
+4.2%
0.00%
Q2 2023$135,938
+36.3%
35,126
-2.4%
0.00%
Q1 2023$99,742
+37.9%
36,008
-10.4%
0.00%
Q4 2022$72,324
+0.4%
40,180
+18.8%
0.00%
Q3 2022$72,000
-28.7%
33,812
-9.4%
0.00%
Q2 2022$101,000
-69.7%
37,312
-51.4%
0.00%
Q1 2022$333,000
+1413.6%
76,731
+1747.6%
0.00%
Q4 2021$22,000
-83.5%
4,153
-80.8%
0.00%
Q3 2021$133,000
+786.7%
21,601
+1340.1%
0.00%
Q2 2021$15,0001,5000.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders